Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema

PaperCitations, authors & open-access status

A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 594 citations, 2005 year and closed oa status.

594
Citations
2005
Year
closed
OA Status

Related on ScholarIQ

Steven D. Schwartz
Author
Ophthalmology
Journal
Retinal Diseases and Treatments
Topic
Retinal Diseases and Treatments
Topic
Diabetes Treatment and Management
Topic
Retinal Development and Disorders
Topic
470M+ articles · free account